相关实验视频

Updated: Jul 9, 2025

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Systemic Delivery of MicroRNA Using Recombinant Adeno-associated Virus Serotype 9 to Treat Neuromuscular Diseases in Rodents

Published on: August 10, 2018

在神经肌肉治疗中,围绕AAV和CRISPR疗法存在安全问题

Harry Wilton-Clark¹, Toshifumi Yokota¹

¹University of Alberta, Department of Medical Genetics, Edmonton, AB, Canada.

Med (New York, N.Y.)

|December 9, 2023

概括

使用CRISPR和腺相关病毒载体 (AAVs) 的基因疗法在神经肌肉疾病方面表现有前途. 然而,最近一例杜恩肌肉衰竭患者的死亡突出了需要进一步调查的关键安全问题.

科学领域:

基因治疗是一种基因疗法.
神经肌肉疾病神经肌肉疾病
在CRISPR技术的应用中.
腺相关病毒载体 (AAVs)

背景情况:

基因疗法正在成为神经肌肉疾病的潜在治疗方法.
在这个领域,CRISPR和AAV矢量是关键技术.
安全问题对临床翻译至关重要.

研究的目的:

要突出与CRISPR和AAV基因疗法相关的潜在风险.
讨论最近在杜氏肌肉衰竭试验中患者死亡的含义.

主要方法:

对神经肌肉疾病的当前基因疗法方法的审查.
从涉及CRISPR和AAVs的临床试验中分析安全数据.
一个Duchenne肌肉发育不良症患者的病例研究检查结果.

主要成果:

基于CRISPR和AAV的基因疗法具有治疗潜力.
最近一项杜琴肌肉衰竭试验导致一名患者死亡.
这一事件强调了严格的安全评估的必要性.

结论:

开发用于神经肌肉疾病的基因疗法必须优先考虑患者的安全.
需要进一步的研究来减轻与CRISPR和AAV传递系统相关的风险.
在广泛临床应用之前,仔细评估风险和益处至关重要.

更多相关视频

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Adeno-Associated Virus-Mediated Delivery of CRISPR for Cardiac Gene Editing in Mice

Published on: August 2, 2018

Intravenous Injections in Neonatal Mice

Intravenous Injections in Neonatal Mice

Published on: November 11, 2014

相关概念视频

CRISPR

CRISPR

Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...

What is Genetic Engineering?

What is Genetic Engineering?